Health Care/Hospital

Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19

Legacy coronavirus biochemistry was overlooked that governs spike protein toxicity, key morbidities, risk factors and therapeutic responses SALT LAKE CITY, April 22, 2024 /PRNewswire/ -- TrialSite News features a paper published today in Viruses (Basel), authored by an international team of resea...

2024-04-22 19:52 782

Yili Innovation Center Europe Kicks Off All-round Upgrades

WAGENINGEN, Netherlands, April 22, 2024 /PRNewswire/ -- On April 18th, local time inthe Netherlands, on the occasion of the 10th anniversary of the establishment of the Yili Innovation Center Europe (YICE), a ceremony themed "Connect Globally to Drive Innovation" was held at Wageningen University...

2024-04-22 19:08 1120

Leo Cancer Care Teams up With World-Leading Carbon Ion Centre

Partnership will see Upright Radiotherapy System Installed at World-Leading Cancer Centre MIDDLETON, Wis., April 22, 2024 /PRNewswire/ -- Leo Cancer Care's unique upright radiotherapy solution is set to be installed in one of the world's most advanced oncology centres to deliver proton and carbo...

2024-04-22 18:43 906

Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer

* Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative breast cancer and pancreatic cancer * Niclosamide-based oral anticancer drug project to be carried out by the new subsidiary of Hyundai Biosci...

2024-04-22 17:51 811

Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions

SHANGHAI, April 22, 2024 /PRNewswire/ -- Themed "Planet vs. Plastics," the 55th Earth Day serves as a deep reminder for everyone to play a role in environmental protection.Angel Yeast , (SH600298), the world's leading yeast and biotechnology company, is actively promot...

2024-04-22 16:00 1905

AGCO Agriculture Foundation Donates $450,000 AUD to Rural Aid Australia

DULUTH, Ga., April 22, 2024 /PRNewswire/ -- The AGCO Agriculture Foundation (the "Foundation"), a private foundation with the vision to prevent and relieve hunger through sustainable agriculture development, announced a$450,000 AUD grant to Rural Aid to support farmers' mental health and wellbein...

2024-04-22 14:00 1058

GT20029 China Phase II Trial For AGA Reached Primary Endpoint

SUZHOU, China, April 21, 2024 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced thatthe China phase II clinical trial (the "Phase II Clinical Trial") of i...

2024-04-22 09:53 1225

Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards

SINGAPORE, April 18, 2024 /PRNewswire/ -- Juniper Biologics

2024-04-22 09:00 904

Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards

SINGAPORE, April 22, 2024 /PRNewswire/ -- Juniper Biologics

2024-04-22 09:00 969

BGI Genomics Leads Innovation with Inaugural Clinical Lab in Uruguay

Cutting-edge facility to serve as a beacon for preventive medicine in Latin America MONTEVIDEO, Uruguay, April 22, 2024 /PRNewswire/ -- BGI Genomics, a global leader in integrated precision medicine solutions, has established a new clinical laboratory atUruguay's Parque de las Ciencias free trad...

2024-04-22 08:27 965

ASTRI's Wins 23 Awards Geneva Inventions Expo

Gemstones Identification Technology Earns Gold Medal with Congratulations of Jury HONG KONG, April 20, 2024 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) has won 23 accolades at the 49th International Exhibition of Inventions Geneva, including 1 "Gold Me...

2024-04-20 16:31 1766

CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US

TAMPA, Fla., April 20, 2024 /PRNewswire/ -- Concept Medical , a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" usingMagicTouch

2024-04-20 01:11 1690

Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success

* To be registered as an official research organization by the National Assembly Secretariat... Expected to become Korea's leading medical think tank * Planning to initiate global multinational clinical projects in digital therapeutics * Establishing a future medical system centered aroun...

2024-04-19 21:00 2241

Concord Medical Files 2023 Annual Report on Form 20-F

BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it filed its annual report on Form 20-F for t...

2024-04-19 20:31 2174

MGI Tech's DNBSEQ-T20x2* Gene Sequencer Named 2024 Edison Award™ Gold Winner

FORT MYERS, Fla., April 19, 2024 /PRNewswire/ -- MGI Tech , a company committed to building core tools and technology to lead life science, is proud to announce that its DNBSEQ-T20x2* gene sequencer has been recognized with a GoldEdison Award

2024-04-19 20:15 935

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

GAITHERSBURG, Md., April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious dise...

2024-04-19 19:00 3267

GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer

SHANGHAI, April 19, 2024 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a mult...

2024-04-19 19:00 1718

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

SEOUL, South Korea, April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com ) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue vi...

2024-04-19 13:17 1446

Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization

SEOUL, South Korea, April 18, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi,www.hyundaibioscience.com ) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue...

2024-04-19 10:54 1816

EARTHDAY.ORG PARTNERS WITH OAAA TO BRING AWARENESS TO THE DANGERS OF PLASTICS TO HUMAN HEALTH

WASHINGTON, April 19, 2024 /PRNewswire/ -- EARTHDAY.ORG, the global force behind Earth Day, is partnering with the Out of Home Advertising Association of America (OAAA), the leading trade group representing the entire out of home (OOH) advertising industry,  for the sixth year in a row! OAAA and ...

2024-04-19 01:45 1563
12345 ... 807